This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Amphista Therapeutics Limited. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Pauline Drouhin: Innovator in Targeted Protein Degradation
Introduction
Pauline Drouhin is a prominent inventor based in Cambridge, GB. She has made significant contributions to the field of biotechnology, particularly in the area of targeted protein degradation. Her innovative work has the potential to advance therapeutic strategies for various diseases.
Latest Patents
Pauline Drouhin holds a patent titled "Compounds for Targeted Protein Degradation." This patent represents her commitment to developing novel compounds that can selectively degrade specific proteins, which is crucial for therapeutic applications.
Career Highlights
Drouhin is currently associated with Amphista Therapeutics Limited, where she continues to push the boundaries of scientific research. Her work at Amphista focuses on harnessing the power of targeted protein degradation to create effective treatments.
Collaborations
Throughout her career, Pauline has collaborated with notable colleagues, including Giles Albert Brown and David McGarry. These partnerships have enriched her research and contributed to the advancement of their shared goals in biotechnology.
Conclusion
Pauline Drouhin is a trailblazer in the field of targeted protein degradation, with a patent that underscores her innovative spirit. Her work at Amphista Therapeutics Limited and collaborations with esteemed colleagues highlight her dedication to advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile